The Gross Margin of XBiotech Inc (XBIT) is
83.79%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2024-12-31 |
83.79%
|
| 2023-12-31 |
83.79%
|
| 2022-12-31 |
68.35%
|
| 2021-12-31 |
21.48%
|
| Ticker |
Name |
Value |
|
JNCE
|
Jounce Therapeutics Inc
|
7775.20%
|
|
MREO
|
Mereo BioPharma Group PLC
|
73.40%
|
|
MRNA
|
Moderna, Inc.
|
70.32%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
86.56%
|
|
SPRO
|
Spero Therapeutics, Inc.
|
7775.20%
|
|
ACET
|
ADICET Bio, Inc.
|
7775.20%
|
|
GERN
|
Geron Corporation
|
97.42%
|
|
DTIL
|
Precision Biosciences, Inc
|
7775.20%
|
|
SLDB
|
Solid Biosciences Inc
|
7775.20%
|
|
XOMA
|
XOMA Royalty Corporation
|
100.00%
|
|
AGEN
|
Agenus Inc
|
99.11%
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
86.02%
|
|
APLT
|
Applied Therapeutics Inc
|
7775.20%
|
|
ARDX
|
Ardelyx, Inc.
|
90.29%
|
|
RAPT
|
RAPT Therapeutics, Inc
|
7775.20%
|
|
SYRS
|
Syros Pharmaceuticals Inc
|
7775.20%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
86.24%
|
|
950220.KQ
|
Neoimmunetech Inc
|
7775.20%
|
|
ALDX
|
Aldeyra Therapeutics Inc
|
7775.20%
|
|
AMGN
|
Amgen Inc
|
70.78%
|
|
BCYC
|
Bicycle Therapeutics PLC
|
7775.20%
|
|
GILD
|
Gilead Sciences, Inc.
|
78.84%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
13.28%
|
|
ABBV
|
AbbVie Inc.
|
71.62%
|
|
ISEE
|
IVERIC bio Inc
|
7775.20%
|
|
NLTX
|
Neoleukin Therapeutics Inc
|
7775.20%
|
|
HARP
|
Harpoon Therapeutics Inc
|
7775.20%
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
7775.20%
|
|
ANAB
|
AnaptysBio, Inc.
|
7775.20%
|
|
INZY
|
Inozyme Pharma Inc
|
7775.20%
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
80.77%
|
|
SELB
|
Selecta Biosciences Inc
|
7775.20%
|
|
950200.KQ
|
Psomagen Inc
|
24.48%
|
|
ALBO
|
Albireo Pharma Inc
|
96.66%
|
|
AVRO
|
AVROBIO Inc
|
7775.20%
|
|
OYST
|
Oyster Point Pharma Inc
|
93.79%
|